Chasteberry (Vitex Agnus-Castus)
Chaste tree is a medicinal plant whose fruit extract relieved premenstrual complaints and cyclical breast pain more strongly than placebo in studies.
We evaluated 79 human studies on Chasteberry (Vitex agnus-castus), including 27 randomised controlled trials and 15 meta-analyses or systematic reviews; the controlled studies include 1,884 participants in total. As of 5 October 2026.
1. What Is Chasteberry (Vitex Agnus-Castus)? Occurrence, Origin and Forms
Chasteberry is a plant in the mint family. Its dried fruits are traditionally used for cyclical complaints in women, such as breast tenderness or symptoms before menstruation. Studies mostly investigate a dry extract of the fruits.
The plant grows in the Mediterranean region and parts of Asia. It is also cultivated in other warm regions. The ripe, dried fruits are used.
Extracts are made from the dried fruits, often as a dry extract with a defined ratio of starting material to extract. Studies mainly use standardised extracts in capsule or tablet form; tea preparations from the fruits are also common, but there are hardly any comparable investigations for them.
Forms and Preparations Studied
- Standardised dry extract of the fruits (capsule or tablet)
- Tea infusion from dried fruits
- Liquid extract or tincture
- Combination products with other plant extracts
Not covered on this page:
- Other mint family plants such as sage or peppermint
- Hormonal medicines that affect the cycle
- Dietary supplements with chasteberry that also contain other substances
2. What Does Chasteberry (Vitex Agnus-Castus) Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Menstrual cycle disorders | mostly improved | high | 8 meta-analyses · 9 controlled · 24 other | 619 |
| Breast tenderness (mastalgia) | mostly improved | high | 5 meta-analyses · 5 controlled · 9 other | 491 |
| Fertility | reviews only | low | 2 meta-analyses · 0 controlled · 3 other | 0 |
| Menopausal symptoms | mostly improved | low | 0 meta-analyses · 1 controlled · 6 other | 52 |
| Other investigations | mostly improved | high | 1 meta-analyses · 7 controlled · 18 other | 322 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Chasteberry (Vitex Agnus-Castus) and Menstrual Cycle Disorders: Human Studies
In premenstrual syndrome (PMS), chaste tree extracts relieved the overall complaints more than placebo, according to two meta-analyses and four randomised studies 2616172425. A systematic review found chaste tree more effective than placebo, vitamin B6 or magnesium oxide in seven of eight PMS studies 11. In premenstrual dysphoric disorder, in a randomised study similar numbers of women responded to the extract as to fluoxetine 33. Fluoxetine relieved rather the psychological, the extract rather the physical complaints 33. In women with polycystic ovary syndrome (PCOS), menstruation occurred more often with chaste tree than with placebo 28. In corpus luteum weakness due to latent hyperprolactinaemia, an extract compared with placebo lowered prolactin release and normalised luteal phase and progesterone 30. Against increased bleeding due to an IUD, chaste tree was weaker than mefenamic acid in the first three months, with no difference in the fourth month 22. A meta-analysis found no difference in bleeding amount compared with placebo 3. A meta-analysis regards the large pooled effect in PMS as preliminary because of high risk of bias and calls for comparisons with placebo, serotonin reuptake inhibitors and the pill 6. Combination preparations do not allow a statement about chaste tree alone. A mixture of St John's wort and chaste tree relieved PMS-like complaints in late menopause more than placebo, studied in a small subgroup 36.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Csupor et al. 2019 | meta-analysis · 520 participants | Vitex agnus-castus extracts Ze 440 and BNO 1095; vs. Placebo | Responder rate (remission of PMS symptoms): improved (2.57 (95% CI 1.52-4.35)) |
| 3 Mollazadeh et al. 2019 | systematic review | Vitex agnus-castus as tablets, capsules, or oral drops; different doses; first and second menstrual cycles; vs. Placebo or mefenamic acid | Mean menstrual bleeding in first cycle (Vitex vs. placebo): no difference (MD: 3.08; 95% CI: -3.11-9.26; p=0.33); Mean menstrual bleeding in second cycle (Vitex vs. placebo): no difference (MD: 0.00; 95% CI: -5.75-5.75; p=1.00); Higham score in first cycle (Vitex vs. mefenamic acid): worsened (MD: 7.17; 95% CI: 0.33-14.01; p=0.04) |
| 5 Maleki-Saghooni et al. 2018 | systematic review | Iranian herbal medicines including Vitex agnus-castus | PMS symptoms: improved |
| 6 Verkaik et al. 2017 | meta-analysis | Vitex agnus castus preparations; at least 2 menstrual cycles; vs. Placebo, dietary supplements, or herbal preparations | Total premenstrual syndrome symptoms: improved (Hedges g, -1.21; 95% confidence interval, -1.53 to -0.88) |
| 7 Cerqueira et al. 2017 | systematic review | Vitex agnus castus (VAC), three different preparations; vs. Placebo or active comparator | Efficacy in PMS/PMDD: improved (all eight studies were positive for VAC) |
| 8 Rafieian-Kopaei et al. 2017 | systematic review | Vitex agnus-castus (extract form not specified) | Treatment of premenstrual syndrome (PMS): improved; Alleviation of postmenstrual pain: improved |
| 9 Izzo et al. 2016 | systematic review | Agnus castus (Vitex agnus castus); vs. not reported | Clinical evidence for premenstrual complaints: improved (preliminary or satisfactory clinical evidence) |
| 11 van et al. 2013 | systematic review | Vitex agnus-castus extracts as sole agent; vs. Placebo, pyridoxine, magnesium oxide, fluoxetine, bromocriptine | Superiority in premenstrual syndrome: improved (seven of eight trials found Vitex extracts to be superior to placebo (5 of 6 studies), pyridoxine (1), and magnesium oxide (1)); Comparison in premenstrual dysphoric disorder: unclear (one study reported Vitex to be equivalent to fluoxetine, while in the other, fluoxetine outperformed Vitex) |
Further studies in this area: 14 16 17 24 25 28 30 33 40 42 45 46 47 48 49 50 52 53 55 57 58 60 61 62 63 64 65 66 67 69 72 73 75
Chasteberry (Vitex Agnus-Castus) and Breast Tenderness (Mastalgia): Human Studies
In cyclic breast pain (mastalgia), chaste tree extract relieved the pain in a meta-analysis of six placebo-controlled studies with a moderate effect size 1. In two randomised studies, breast pain decreased more than with placebo, with tablets 18 and with drops 41. A meta-analysis also found a decrease in elevated prolactin levels 1. Premenstrual breast tenderness in PMS also decreased more than with placebo 17 or with vitamin B6 42. Compared with medications such as dopamine agonists, NSAID-type painkillers, serotonin reuptake inhibitors and hormonal contraception, chaste tree was not inferior in seven studies of a meta-analysis 1. A systematic review reports from one study a relief comparable to bromocriptine 11. It is open whether the relief persists beyond the first months; after three cycles, the lead over placebo in one study was only borderline 41.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ooi et al. 2020 | meta-analysis · 718 participants | Vitex agnus-castus (VAC); 20-40 mg/day; 3 months; vs. Placebo; also dopamine agonists, NSAIDs, serotonin reuptake inhibitors, hormonal contraceptives | Breast pain intensity: improved (SMD: 0.67, 95% CI: 0.5-0.85); Increased serum prolactin level: improved; Noninferiority to pharmaceutical therapies: no difference |
| 8 Rafieian-Kopaei et al. 2017 | systematic review | Vitex agnus-castus (extract form not specified) | Treatment of premenstrual mastodynia: improved |
| 11 van et al. 2013 | systematic review | Vitex agnus-castus extracts as sole agent; vs. Placebo, pyridoxine, magnesium oxide, fluoxetine, bromocriptine | Cyclic mastalgia compared with bromocriptine: no difference (comparable to bromocriptine for reducing serum prolactin levels and ameliorating cyclic mastalgia) |
| 13 Carmichael et al. 2008 | systematic review | Vitex agnus castus fruit extract; vs. randomized and non-randomized studies | Efficacy in mastalgia: improved |
| 14 Dennehy et al. 2006 | systematic review | Chasteberry, extract form not specified; vs. Evidence-based evaluation of randomized controlled trial evidence | Level of evidence support for cyclic mastalgia: improved |
| 16 Schellenberg et al. 2001 | randomised controlled · 170 participants | Agnus castus dry extract Ze 440 tablets; one tablet daily; three consecutive menstrual cycles; vs. placebo, double blind, randomised | breast fullness as part of main variable: improved (P<0.001) |
| 17 Schellenberg et al. 2012 | randomised controlled · 162 participants | Vitex agnus castus extract Ze 440; 8, 20 or 30 mg daily; three menstrual cycles; vs. placebo | single PMS symptom score breast fullness: improved |
| 18 Mirghafourvand et al. 2016 | randomised controlled · 159 participants | Vitex agnus tablet (3.2–4.8 mg daily) vs. flaxseed powder vs. placebo; 3.2–4.8 mg Vitex agnus daily; 2 months; vs. Placebo and flaxseed powder 25 g daily | Nominal Day Breast Pain score at 1 month: improved (-3.3 (-4.3 to -2.2)); Nominal Day Breast Pain score at 2 months: improved (-6.4 (-7.5 to -5.3)) |
Further studies in this area: 41 42 45 47 50 53 54 61 64 73 75
Chasteberry (Vitex Agnus-Castus) and Fertility: Human Studies
Hypothesis Systematic reviews see preliminary evidence of a benefit in unfulfilled desire to have children 814. The combination preparation FertilityBlend of chaste tree, green tea, L-arginine, vitamins and minerals led to more pregnancies in two placebo-controlled studies 4344. What share chaste tree has in this is open. The homeopathic complex remedy Phyto-Hypophyson L with chaste tree did not increase the birth rate compared with placebo in a randomised study 26. A study with chaste tree alone that measures pregnancy rate as the target is open.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 8 Rafieian-Kopaei et al. 2017 | systematic review | Vitex agnus-castus (extract form not specified) | Treatment of infertility in men and women: improved |
| 14 Dennehy et al. 2006 | systematic review | Chasteberry, extract form not specified; vs. Evidence-based evaluation of randomized controlled trial evidence | Preliminary support in infertility: unclear |
| 48 Antoine et al. 2019 | study · 189 participants | tablet with Vitex extract, Maca extract and active folate (patented blend); one tablet daily; 18 months (study period June 2016–December 2017); vs. Group A (blend alone) vs. Group B (blend plus vitamin/mineral capsule) | pregnancy rate: improved (37%) |
| 61 2006 | review · 352 participants | Chasteberry fruit, tincture and extracts; low and high doses | Infertility: unclear |
| 75 Gorkow et al. 2002 | review | ACF preparations of Vitex agnus-castus; vs. Placebo in double-blind studies, otherwise open studies | Success rates in fertility disorders: unclear |
Chasteberry (Vitex Agnus-Castus) and Menopausal Symptoms: Human Studies
In menopausal complaints, a chaste tree extract in a randomised study lowered the total score, anxiety and vasomotor complaints more than placebo 29. Physical complaints, depression and sexual function did not differ 29. A mixture of chaste tree, fennel and carrot seeds improved quality of life and sexual function after menopause more than placebo 21. Chaste tree with soy isoflavones, black cohosh and evening primrose oil relieved hot flushes, sleep problems and depressive mood more than placebo 37. In addition to citalopram, black cumin and chaste tree improved vasomotor, physical and psychosocial complaints more than citalopram with placebo 31. A capsule of black cohosh, soy, potato, chaste tree and burdock lowered night sweats, but not hot flushes 39. St John's wort with chaste tree, by contrast, was not more effective than placebo; both groups improved 20. Larger studies with chaste tree alone are still pending; how much it contributes to the effects of the mixtures is open.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 10 Ghazanfarpour et al. 2016 | systematic review | Iranian herbal medicines, including Vitex agnus castus; vs. Placebo or control (not specified) | Hot flashes: improved |
| 29 Naseri et al. 2019 | randomised controlled · 52 participants | Vitex agnus-castus extract (phytoestrogenic); 8 weeks; vs. Placebo | Total menopausal disorder score (Greene Scale): improved (P<0.05); Anxiety score (Greene Scale): improved (P<0.05); Vasomotor dysfunction (Greene Scale): improved (P<0.05) |
| 51 Chopin et al. 2003 | study · 52 participants | Vitex agnus castus essential oil (leaf and fruit derived separately); Summer 2002 | Symptomatic relief of menopausal symptoms: improved |
| 54 Choudhury et al. 2025 | study · 30 participants | Arth Perimenopause Multisymptom Support capsules (vitex, ashwagandha, black cohosh); one capsule daily; 60 days; vs. no control group, before-after comparison | Menopause Rating Scale (MRS): improved (39 at baseline to 2.74 by day 60 (-92.97%, p < 0.01)); complete resolution of hot flashes: improved (93%); complete resolution of sweating: improved (88%) |
| 67 Dietz et al. 2016 | review | Vitex agnus-castus (chasteberry) | Estrogenic activity for symptom relief: unclear |
| 68 Hajirahimkhan et al. 2013 | review | Botanical extracts including chasteberry | Efficacy for menopausal symptom relief: unclear (controversial) |
| 74 Russell et al. 2002 | review | Chaste tree (Vitex agnus-castus) among other herbs | Efficacy and safety for menopausal symptoms |
Chasteberry (Vitex Agnus-Castus): Further Outcomes in Studies
In women with polycystic ovary syndrome, standardized chaste tree extract lowered oxidative stress, insulin resistance and LDL compared with placebo and increased HDL 28. A placebo-controlled analysis in PCOS also found lower inflammatory markers (TNF-α, IL-6) and a reduced anti-Müllerian hormone 34. In women of childbearing age, chaste tree improved the overall score of sexual function more strongly than placebo after four months, but not individual domains 38. After bone fractures, under chaste tree the vascular growth factor VEGF increased only compared with baseline; callus formation did not differ between the groups 27. In PCOS, the Unani combination preparation Picolin made from cinnamon, licorice, flaxseed and chaste tree lowered insulin and prolactin compared with baseline, whereas metformin did not 23. The combination preparation PREMEN-CALM made from γ-aminobutyric acid, rhodiola, chaste tree, vitamin B6 and melatonin improved mood and antioxidant status in PMS only compared with baseline, not compared with placebo 32.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 4 Yeung et al. 2018 | systematic review | Single-herb extracts, including chasteberry; vs. conventional anxiolytics/antidepressants | anxiety or depressive symptoms: improved |
| 11 van et al. 2013 | systematic review | Vitex agnus-castus extracts as sole agent; vs. Placebo, pyridoxine, magnesium oxide, fluoxetine, bromocriptine | TRH-stimulated prolactin secretion, luteal phase, progesterone, 17β-oestradiol: improved (superior to placebo for reducing TRH-stimulated prolactin secretion, normalising a shortened luteal phase, increasing mid-luteal progesterone and 17β-oestradiol levels) |
| 12 Posadzki et al. 2013 | systematic review | Vitex agnus-castus (chasteberry) among 50 herbal medicines | Adverse effects |
| 15 Daniele et al. 2005 | systematic review | Vitex agnus castus monopreparations (fruit extract); vs. no comparator (safety data from trials, spontaneous reports, manufacturers) | Most frequent adverse events; Drug interactions (No drug interactions were reported) |
| 16 Schellenberg et al. 2001 | randomised controlled · 170 participants | Agnus castus dry extract Ze 440 tablets; one tablet daily; three consecutive menstrual cycles; vs. placebo, double blind, randomised | responder rate (50% reduction in symptoms): improved (52% and 24%); clinical global impression (three items): improved (P<0.001) |
| 28 Hatami et al. 2026 | randomised controlled · 60 participants | standardized Vitex agnus-castus extract; 5.8 mg daily, standardized to 0.42-0.82 mg Aucubin; 12 weeks; vs. placebo | total antioxidant capacity: improved (effect size = 13.01); glutathione peroxidase: improved (3.35); reduced glutathione: improved (3.88) |
| 30 Milewicz et al. 1993 | randomised controlled · 52 participants | Vitex agnus castus extract (Strotan capsules); 1 capsule (20 mg) daily; 3 months; vs. Placebo, randomized double-blind | 17 beta-estradiol in luteal phase: improved |
| 34 Hatami et al. 2026 | randomised controlled · 40 participants | Vitex agnus-castus standardized to 0.42-0.82 mg aucubin; 5.8 mg/day; 12 weeks; vs. Placebo | Serum TNF-α: improved (141.27 ± 24.27 to 91.28 ± 19.57 pg/mL); Serum IL-6: improved (71.72 ± 13.63 to 48.91 ± 24.19 pg/mL); Anti-Mullerian hormone (AMH): improved (11.21 ± 3.89 to 7.88 ± 4.87 ng/mL) |
Further studies in this area: 38 40 42 45 47 49 52 53 55 56 58 59 60 61 66 70 71 73
4. How Is Chasteberry (Vitex Agnus-Castus) Dosed? Preparation, Dose and Duration in Studies
Mainly standardised dry extracts from the fruits in capsule or tablet form were studied 161724252830. For cyclic breast pain, a solution with chaste tree extract as drops was also tested 41. As a tea, chaste tree was tested only in a mixture with fennel and horsemint (Mentha longifolia) 35.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| Agnus castus dry extract Ze 440 tablets | one tablet daily | three consecutive menstrual cycles | 16 |
| Vitex agnus castus extract Ze 440 | 8, 20 or 30 mg daily | three menstrual cycles | 17 |
| Vitex agnus tablet (3.2–4.8 mg daily) vs. flaxseed powder vs. placebo | 3.2–4.8 mg Vitex agnus daily | 2 months | 18 |
| Nutraceutical with Glycine max, Cimicifuga racemosa, Vitex agnus-castus, Oenothera biennis | — | 12 weeks | 19 |
| Combination of Hypericum perforatum and Vitex agnus-castus (tablets) | twice daily | 16 weeks | 20 |
| Jazar capsules (Vitex, fennel, carrot seeds) | 4 capsules of 500 mg daily | 8 weeks | 21 |
| Vitex agnus castus capsules vs. mefenamic acid | three times a day during menstruation | 4 months | 22 |
| Capsule Picolin or tablet Picolin-E (polyherbal, containing Vitex agnus castus) | Picolin 500 mg two capsules thrice daily; Picolin-E 250 mg thrice daily | 12 weeks | 23 |
| Vitex agnus castus extract BNO 1095 | — | three cycles | 24 |
| Vitex agnus castus extract BNO 1095, one tablet | one tablet once daily | 3 cycles | 25 |
| Phyto-Hypophyson L, Agnus castus-containing homeopathic preparation | 50 drops 3 times daily | 3 months or 3 cycles | 26 |
| Agnugol tablet (4 mg dried Vitex agnus castus fruit extract) | 1 tablet plus 250 mg magnesium oxide daily | 8 weeks | 27 |
| standardized Vitex agnus-castus extract | 5.8 mg daily, standardized to 0.42-0.82 mg Aucubin | 12 weeks | 28 |
| Vitex agnus-castus extract (phytoestrogenic) | — | 8 weeks | 29 |
| Vitex agnus castus extract (Strotan capsules) | 1 capsule (20 mg) daily | 3 months | 30 |
5. Is Chasteberry (Vitex Agnus-Castus) Safe? Side Effects in Studies
The studies report mainly mild and temporary adverse events 171113. A systematic review most frequently names nausea, headache, gastrointestinal complaints, cycle disorders, acne, itching and skin rash; interactions were not reported 15. The review advises avoiding chaste tree during pregnancy and breastfeeding, and considers interactions with dopamine antagonists conceivable 15.
| Study | Reported side effects |
|---|---|
| 1 Ooi et al. 2020 | Safe, only mild and reversible adverse events |
| 3 Mollazadeh et al. 2019 | Nausea and abdominal pain reported |
| 4 Yeung et al. 2018 | fewer adverse effects than conventional medications |
| 5 Maleki-Saghooni et al. 2018 | Safety reported, no details |
| 6 Verkaik et al. 2017 | Tolerability and acceptability assessed but not reported |
| 7 Cerqueira et al. 2017 | VAC overall well tolerated |
| 9 Izzo et al. 2016 | Potentially serious adverse events and herb-drug interactions described |
| 11 van et al. 2013 | Mild and generally infrequent |
| 12 Posadzki et al. 2013 | Minor adverse effects reported for Vitex agnus-castus |
| 13 Carmichael et al. 2008 | mild and reversible |
| 15 Daniele et al. 2005 | Nausea, headache, gastrointestinal disturbances, menstrual disorders, acne, pruritus, rash; mild and reversible |
| 16 Schellenberg et al. 2001 | Seven women reported mild events (four active, three placebo), no discontinuations |
6. What Remains Open: Limits of the Evidence
- Many controlled studies are small, and they use different extracts and measurement scales 7.
- The optimal dose and the comparability of different extract forms are open.
- Controlled studies on tea or tincture from chaste tree alone are still pending.
- Whether a benefit persists with longer use is not clarified.
7. Bottom Line: What Is Established About Chasteberry (Vitex Agnus-Castus)
Chaste tree is most frequently studied as a standardised dry extract from the fruits in capsule or tablet form. The best documented is the relief of PMS and cyclic breast pain compared with placebo 12. In menopausal complaints, corpus luteum weakness and polycystic ovary syndrome, individual placebo-controlled studies showed advantages 282930.
Next, larger studies with chaste tree alone are needed, especially on menopause and desire to have children, and longer observation periods.
Frequently Asked Questions
How well has Chasteberry (Vitex agnus-castus) been studied in humans?
We evaluated 79 human studies on Chasteberry (Vitex agnus-castus), including 27 randomised controlled trials and 15 meta-analyses or systematic reviews; the controlled studies include 1,884 participants in total. As of 5 October 2026.
Does Chasteberry (Vitex agnus-castus) help with menstrual cycle disorders? What the studies show
Does Chasteberry (Vitex agnus-castus) help with breast tenderness (mastalgia)? What the studies show
Does Chasteberry (Vitex agnus-castus) help with fertility? What the studies show
Does Chasteberry (Vitex agnus-castus) help with menopausal symptoms? What the studies show
Which form of chaste tree was studied in the studies?
What do the studies show for breast tenderness (mastalgia)?
Is there evidence of a benefit for fertility?
How well tolerated is chaste tree?
The studies report mainly mild and temporary adverse events 171113. A systematic review most frequently names nausea, headache, gastrointestinal complaints, cycle disorders, acne, itching and skin rash; interactions were not reported 15. The review advises avoiding chaste tree during pregnancy and breastfeeding, and considers interactions with dopamine antagonists conceivable 15.
Can combination preparations with chaste tree be assessed?
Combination preparations do not allow a statement about chaste tree alone. A mixture of St John's wort and chaste tree relieved PMS-like complaints in late menopause more than placebo, studied in a small subgroup 36. For an attribution, studies would be needed in which the extract is the difference between the groups.
Sources
- 1Ooi SL, Watts S, McClean R, Pak SC · 2020
- 2Csupor D, Lantos T, Hegyi P, Benkő R, Viola R, Gyöngyi Z et al. · 2019
- 3Mollazadeh S, Mirghafourvand M, Abdollahi NG · 2019
- 4Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J · 2018
- 5The effectiveness and safety of Iranian herbal medicines for treatment of premenstrual syndrome: A systematic reviewMaleki-Saghooni N, Karimi FZ, Behboodi Moghadam Z, Mirzaii Najmabadi K · 2018
- 6Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ · 2017
- 7Cerqueira RO, Frey BN, Leclerc E, Brietzke E · 2017
- 8Rafieian-Kopaei M, Movahedi M · 2017
- 9Izzo AA, Hoon-Kim S, Radhakrishnan R, Williamson EM · 2016
- 10Ghazanfarpour M, Sadeghi R, Abdolahian S, Latifnejad Roudsari R · 2016
- 11van Die MD, Burger HG, Teede HJ, Bone KM · 2013
- 12Posadzki P, Watson LK, Ernst E · 2013
- 13
- 14
- 15Daniele C, Thompson Coon J, Pittler MH, Ernst E · 2005
- 16
- 17Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C · 2012
- 18Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Ahmadpour P, Javadzadeh Y · 2016
- 19Tumsutti P, Maiprasert M, Sugkraroek P, Wanitphakdeedecha R, Bumrungpert A · 2022
- 20van Die MD, Burger HG, Bone KM, Cohen MM, Teede HJ · 2009
- 21Hafizi S, Abbassian A, Tabarrai M · 2021
- 22Yavarikia P, Shahnazi M, Hadavand Mirzaie S, Javadzadeh Y, Lutfi R · 2013
- 23Analysis of Unani coded formulation on the hormonal parameters of patients with polycystic ovarian syndromeHameed L, Farooq AD, Qureshi T · 2021
- 24Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X · 2010
- 25Ma L, Lin S, Chen R, Wang X · 2010
- 26Bergmann J, Luft B, Boehmann S, Runnebaum B, Gerhard I · 2000
- 27Effects of "vitex agnus castus" extract and magnesium supplementation, alone and in combination, on osteogenic and angiogenic factors and fracture healing in women with long bone fractureEftekhari MH, Rostami ZH, Emami MJ, Tabatabaee HR · 2014
- 28Hatami A, Seidi F, Khosrowbeygi A, Moslemi A, Jalali-Mashayekhi F · 2026
- 29Naseri R, Farnia V, Yazdchi K, Alikhani M, Basanj B, Salemi S · 2019
- 30[Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T et al. · 1993
- 31Molaie M, Darvishi B, Jafari Azar Z, Shirazi M, Amin G, Afshar S · 2019
- 32Herrera A, Al Adib M, Rodríguez AB, Carrasco C · 2024
- 33Atmaca M, Kumru S, Tezcan E · 2003
- 34Hatami A, Taheri H, Khosrowbeygi A, Seidi F, Azimi M, Jalali-Mashayekhi F · 2026
- 35Falahat F, Ayatiafin S, Jarahi L, Mokaberinejad R, Rakhshandeh H, Feyzabadi Z et al. · 2020
- 36van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ · 2009
- 37Rattanatantikul T, Maiprasert M, Sugkraroek P, Bumrungpert A · 2022
- 38Heirati SFD, Ozgoli G, KabodMehri R, Mojab F, Sahranavard S, Nasiri M · 2021
- 39Shayan A, Masoumi SZ, Kazemi F, Oshvandi K · 2020
- 40He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S et al. · 2009
- 41Halaska M, Beles P, Gorkow C, Sieder C · 1999
- 42Lauritzen C, Reuter HD, Repges R, Böhnert KJ, Schmidt U · 1997
- 43Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in womenWestphal LM, Polan ML, Trant AS · 2006
- 44A nutritional supplement for improving fertility in women: a pilot studyWestphal LM, Polan ML, Trant AS, Mooney SB · 2004
- 45Höller M, Steindl H, Abramov-Sommariva D, Kleemann J, Loleit A, Abels C et al. · 2024
- 46Drebka A, Scholl AJ, Ochs T, Kelber O, Mösges R, Bachmeier BE · 2026
- 47Loch EG, Selle H, Boblitz N · 2000
- 48
- 49Ambrosini A, Di Lorenzo C, Coppola G, Pierelli F · 2013
- 50Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K · 2014
- 51
- 52Berger D, Schaffner W, Schrader E, Meier B, Brattström A · 2000
- 53O'Gorman E, Kaunzner UW, Mitschke S · 2026
- 54Choudhury R, Coelho K, Suryawanshi S, Hajare A, Kumar A · 2025
- 55Grandi G, Facchinetti F, Melotti C, Sgandurra A · 2023
- 56Akad M, Socolov D, Akad F, Covali R, Crauciuc E, Stan C et al. · 2022
- 57
- 58Hormonal Regulation In Pcos Using Acupuncture And Herbal Supplements: A Case Report And Review Of The LiteratureAlois M, Estores IM · 2019
- 59Farmer C, Barnard J, Zhu J · 2018
- 60[Vitex Agnus Castus in the treatment of hyperprolactinemia and menstrual disorders - a case report]Męczekalski B, Czyżyk A · 2015
- 61Chasteberry· 2006
- 62Bashir S, Shah IM, Javeed S, Rafiquee A, Mir B, Hassan Mir R et al. · 2026
- 63Puglia LT, Lowry J, Tamagno G · 2023
- 64Kamal N, Mio Asni NS, Rozlan INA, Mohd Azmi MAH, Mazlan NW, Mediani A et al. · 2022
- 65Fisher CY, Adams J, Frawley JE, Hickman LD, Sibbritt DW · 2019
- 66Chan EWC, Wong SK, Chan HT · 2018
- 67Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL · 2016
- 68Hajirahimkhan A, Dietz BM, Bolton JL · 2013
- 69
- 70Grant P, Ramasamy S · 2012
- 71Mazaro-Costa R, Andersen ML, Hachul H, Tufik S · 2010
- 72[The premenstrual syndrome: effectiveness of Vitex agnus castus]Döll M · 2009
- 73Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlová-Wuttke D · 2003
- 74Russell L, Hicks GS, Low AK, Shepherd JM, Brown CA · 2002
- 75Gorkow C, Wuttke W, März RW · 2002
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.